KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Nov 17, 2026 - 1:34PM >>  ABB India 6924.75  [ 0.58% ]  ACC 1242.65  [ 1.68% ]  Ambuja Cements 387.85  [ 1.40% ]  Asian Paints 2651.75  [ 2.74% ]  Axis Bank 1370.8  [ 2.30% ]  Bajaj Auto 10790  [ 0.75% ]  Bank of Baroda 274.5  [ 1.61% ]  Bharti Airtel 2163.3  [ 0.53% ]  Bharat Heavy 432.6  [ 0.70% ]  Bharat Petroleum 306.6  [ 0.52% ]  Britannia Industries 4710.2  [ -0.84% ]  Cipla 1391.9  [ -0.15% ]  Coal India 390  [ -2.01% ]  Colgate Palm 1718.4  [ 0.96% ]  Dabur India 384.1  [ 1.07% ]  DLF 768.3  [ 1.76% ]  Dr. Reddy's Lab. 1379.2  [ -0.06% ]  GAIL (India) 187.7  [ 0.62% ]  Grasim Industries 3072  [ -0.10% ]  HCL Technologies 1359.2  [ -1.68% ]  HDFC Bank 819.05  [ 0.37% ]  Hero MotoCorp 5355  [ 0.21% ]  Hindustan Unilever 2010.15  [ 0.66% ]  Hindalco Industries 928.35  [ 0.36% ]  ICICI Bank 1607.6  [ 1.53% ]  Indian Hotels Co. 901.55  [ 1.87% ]  IndusInd Bank 925  [ 1.43% ]  Infosys 1131.7  [ -1.05% ]  ITC 293.35  [ -0.49% ]  Jindal Steel 1132.2  [ 0.19% ]  Kotak Mahindra Bank 497.2  [ 0.81% ]  L&T 4203.15  [ 1.58% ]  Lupin 1960  [ -0.63% ]  Mahi. & Mahi 3416.8  [ 1.99% ]  Maruti Suzuki India 12714  [ 1.12% ]  MTNL 24.98  [ -1.03% ]  Nestle India 1292.7  [ -0.19% ]  NIIT 71.64  [ -0.40% ]  NMDC 69.44  [ 0.77% ]  NTPC 319.85  [ -0.36% ]  ONGC 224.55  [ -0.95% ]  Punj. NationlBak 149.3  [ 3.39% ]  Power Grid Corpn. 257.45  [ -1.74% ]  Reliance Industries 1351.95  [ 0.74% ]  SBI 1109.75  [ 1.81% ]  Vedanta 255.6  [ 0.95% ]  Shipping Corpn. 259.5  [ -2.02% ]  Sun Pharmaceutical 1882.4  [ 0.83% ]  Tata Chemicals 637.5  [ 4.17% ]  Tata Consumer 1117.1  [ 0.13% ]  Tata Motors Passenge 260.65  [ -0.59% ]  Tata Steel 181.9  [ 0.08% ]  Tata Power Co. 344.15  [ -0.25% ]  Tata Consult. Serv. 2426  [ 1.04% ]  Tech Mahindra 1761  [ -1.26% ]  UltraTech Cement 12379.75  [ 0.99% ]  United Spirits 1445  [ 0.26% ]  Wipro 191.3  [ -1.14% ]  Zee Entertainment 71.41  [ -0.35% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

WANBURY LTD.

17 November 2026 | 01:19

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE107F01022 BSE Code / NSE Code 524212 / WANBURY Book Value (Rs.) 42.25 Face Value 10.00
Bookclosure 20/02/2025 52Week High 359 EPS 18.91 P/E 9.39
Market Cap. 620.66 Cr. 52Week Low 162 P/BV / Div Yield (%) 4.20 / 0.00 Market Lot 1.00
Security Type Other

NOTES TO ACCOUNTS

You can view the entire text of Notes to accounts of the company for the latest year
Year End :2026-03 

t. Provisions, contingent Liabilities, contingent assets and commitments :

Provision(legal and constructive) are recognised when the Company has a present obligation (legal or constructive)
as a result of past event and it is probable that an outflow of resources will be required to settle the obligation in
respect of which a reliable estimate can be made. If effect of the time value of money is material, provisions are
discounted using an appropriate discount rate that reflects, when appropriate, the risks specific to the liability. When
discounting is used, the increase in the provision due to the passage of time is recognised as a finance cost.
Provisions (excluding retirement benefits and compensated absences) are not discounted to its present value and
are determined based on best estimate required to settle the obligation at the balance sheet date. These are reviewed
at each balance sheet date and adjusted to reflect the current best estimates.

Contingent liabilities are disclosed in the Notes to the Financial Statements. Contingent liabilities are disclosed for;

• A present obligation arising from past events, when it is not probable that an outflow of resources will be
required to settle the obligation;

• A present obligation arising from past events, when no reliable estimates is possible;

• A possible obligation arising from past events, unless the probability of outflow of resources is remote.
Contingent liabilities are not recognised but disclosed in the financial statements. Contingent assets are neither
recognised nor disclosed in the financial statements.

Commitments include the amount of purchase order (net of advances) issued to parties for completion of assets and
Non-cancellable operating lease.

Provisions, contingent liabilities, contingent assets and commitments are reviewed at each balance sheet date.

u. Fair value measurement:

The Company measures financial instruments, such as, derivatives at fair value at each balance sheet date in
accordance with Ind AS 113. Financial Statements have been prepared on the historical cost basis except for the
following material items in the statement of financial position;

• Derivative financial instruments, if any, are measured at fair value received from Bank.

• Employee Stock Option Plan (ESOP) at fair value as per Actuarial Valuation Report.

Fair value is the price that would be received to sell an asset or settle a liability in an ordinary transaction between
market participants at the measurement date.

The fair value of an asset or a liability is measured using the assumptions that market participants would use when
pricing the asset or liability, assuming that market participants act in their economic best interest.

A fair value measurement of a non-financial asset takes into account a market participant's ability to generate
economic benefits by using the asset in its highest and best use or by selling it to another market participant that
would use the asset in its highest and best use.

The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data
are available to measure fair value, maximising the use of relevant observable inputs and minimising the use of
unobservable inputs.

All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorised
within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value
measurement as a whole:

• Level 1 — Quoted (unadjusted) market prices in active markets for identical assets or liabilities.

• Level 2 — Valuation techniques for which the lowest level input that is significant to the fair value measurement
is directly or indirectly observable.

• Level 3 — Valuation techniques for which the lowest level input that is significant to the fair value measurement
is unobservable.

For assets and liabilities that are recognised in the financial statements on a recurring basis, Company determines
whether transfers have occurred between levels in the hierarchy by reassessing categorization (based on the lowest
level input that is significant to the fair value measurement as a whole) at the end of each reporting period.

For the purpose of fair value disclosures, the Company has determined classes of assets and liabilities on the basis
of the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy as explained
above.

v. Exceptional Items

Exceptional items are disclosed separately in the financial statements where it is necessary to do so to provide
further understanding of the financial performance of the Company. These are material items of income or expense
that have to be shown separately due to the significance of their nature or amount.

7. CRITICAL ACCOUNTING JUDGEMENTS, ESTIMATES AND ASSUMPTIONS:

The preparation of Company's financial statements in conformity with Ind AS requires management to make judgments,
estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities,
income and expenses and the disclosure of contingent liabilities on the date of the financial statements. Actual results
could differ from those estimates. Estimates and under lying assumptions are reviewed on an ongoing basis. Any revision
to accounting estimates is recognised prospectively in current and future periods.

a. Property, plant and equipment :

Determination of the estimated useful life of tangible assets and the assessment as to which components of the cost
may be capitalized. Useful life of tangible assets is based on the life prescribed in Schedule II of the Companies Act,
2013. Assumptions also need to be made, when Company assesses, whether an asset may be capitalised and which
components of the cost of the asset may be capitalised.

b. Allowance for Inventories :

Management reviews the inventory age listing on a periodic basis. The review involves comparison of the carrying
value of the aged inventory items with the respective net realizable value. The purpose is to ascertain whether an
allowance is required to be made in the financial statement for any obsolete and slow-moving items. Management
is satisfied that adequate allowance for obsolete and slow-moving inventories has been made in the Company's
financial statements.

Management also reviews net realisable value for all its inventory and is satisfied that adequate allowance has been
made in the financial statements.

c. Intangible Assets :

Internal technical or user team assesses the remaining useful lives of Intangible assets. Management believes that
assigned useful lives are reasonable.

d. Recognition and measurement of defined benefit obligations :

The obligation arising from the defined benefit plan is determined on the basis of actuarial assumptions. Key actuarial
assumptions include discount rate, trends in salary escalation and vested future benefits and life expectancy. The
discount rate is determined with reference to market yields at the end of the reporting period on the government
bonds. The period to maturity of the underlying bonds correspond to the probable maturity of the post-employment
benefit obligations.

e. Recognition of deferred tax assets and income tax :

Deferred tax asset is recognised for all the deductible temporary differences to the extent that it is probable that
taxable profit will be available against which the deductible temporary difference can be utilised. The management
assumes that taxable profits will be available while recognising deferred tax assets.

Management judgment is required for the calculation of provision for income taxes and deferred tax assets and
liabilities. The Company reviews at each balance sheet date the carrying amount of deferred tax assets. The factors
used in estimates may differ from actual outcome which could lead to significant adjustment to the amounts reported
in the financial statements.

f. Recognition and measurement of other provisions :

The recognition and measurement of other provisions are based on the assessment of the probability of an outflow
of resources, and on past experience and circumstances known at the balance sheet date. The actual outflow of
resources at a future date may, therefore, vary from the figure included in other provisions.

g. Contingencies :

Management judgement is required for estimating the possible outflow of resources, if any, in respect of contingencies/
claim/litigations against the Company as it is not possible to predict the outcome of pending matters with accuracy.

h. Allowance for uncollected accounts receivable and advances :

Trade receivables do not carry any interest and are stated at values as reduced by appropriate allowances for
estimated irrecoverable amounts. Individual trade receivables are written off when management considers them not
collectible. Impairment is made on the expected credit losses, which are the present value of the cash shortfall over
the expected life of the financial assets.

The impairment provisions for financial assets are based on assumption about risk of default and expected loss rates.
Judgement in making these assumptions and selecting the inputs to the impairment calculation are based on past
history, existing market condition as well as forward looking estimates at the end of each reporting period.

i. Insurance Claims :

Insurance claims are recognised when the Company has reasonable certainty of recovery.

j. Impairment Reviews :

Impairment exists when the carrying value of an non-financial asset or cash generating unit ('CGU') exceeds its
recoverable amount. Recoverable amount is the higher of its fair value less costs to sell and its value in use. The
value in use calculation is based on a discounted cash flow model. In calculating the value in use, certain assumptions
are required to be made in respect of highly uncertain matters, including management's expectations of growth in
EBITDA, long term growth rates; and the selection of discount rates to reflect the risks involved.

8. RECENT ACCOUNTING PRONOUNCEMENTS:

8.1 The Company applied for the first-time certain standards and amendments, which are effective for annual periods beginning
on or after 01 April 2025. The Company has not early adopted any standard, interpretation or amendment that has been
issued but is not yet effective.

i. Lack of exchangeability - Amendments to Ind AS 21

The Ministry of Corporate Affairs notified amendments to Ind AS 21 The Effects of Changes in Foreign Exchange
Rates to specify how an entity should assess whether a currency is exchangeable and how it should determine a spot
exchange rate when exchangeability is lacking. The amendments also require disclosure of information that enables
users of its financial statements to understand how the currency not being exchangeable into the other currency

affects, or is expected to affect, the entity's financial performance, financial position and cash flows.

The amendments are effective for annual reporting periods beginning on or after 01 April 2025.

The application of Ind AS 21 does not have material impact on these financial statements of the Company.

ii. Classification of liabilities as current or non-current and non-current liabilities with Covenants - Amendments
to Ind AS 1

The Ministry of Corporate Affairs notified amendments to paragraphs 69 to 76 of Ind AS 1 Presentation of Financial
Statements to specify the requirements for classifying liabilities as current or non-current. The amendments clarify:

• What is meant by a right to defer settlement

• That a right to defer must exist at the end of the reporting period

• That classification is unaffected by the likelihood that an entity will exercise its deferral right

• That only if an embedded derivative in a convertible liability is itself an equity instrument would the terms of a liability
not impact its classification

The amendments are effective for annual reporting periods beginning on or after 01 April, 2025.

The application of Ind AS 1 does not have material impact on these financial statements of the Company.

iii. Supplier Finance Arrangements - Amendments to Ind AS 7 and Ind AS 107

The Ministry of Corporate Affairs notified amendments to Ind AS 7 Statement of Cash Flows and Ind AS 107 Financial
Instruments: Disclosures to clarify the characteristics of supplier finance arrangements and require additional
disclosure of such arrangements. The disclosure requirements in the amendments are intended to assist users of
financial statements in understanding the effects of supplier finance arrangements on an entity's liabilities, cash flows
and exposure to liquidity risk.

The amendments are effective for annual reporting periods beginning on or after 01 April, 2025.

The application of Ind AS 7 and 107 does not have material impact on these financial statements of the Company.

iv. International Tax Reform—Pillar Two Model Rules - Amendments to Ind AS 12

The Ministry of Corporate Affairs notified amendments to Ind AS 12 Income Taxes in response to the OECD's BEPS
Pillar Two rules and include:

• A mandatory temporary exception to the recognition and disclosure of deferred taxes arising from the
jurisdictional implementation of the Pillar Two model rules; and

• Disclosure requirements for affected entities to help users of the financial statements better understand an
entity's exposure to Pillar Two income taxes arising from that legislation, particularly before its effective date.

The mandatory temporary exception - the use of which is required to be disclosed - applies immediately. The
remaining disclosure requirements apply for annual reporting periods beginning on or after April 01, 2025, but
not for any interim periods ending on or before 31 March 2026.

The amendments are effective for annual reporting periods beginning on or after 01 April, 2025.

The application of Ind AS 12 does not have material impact on these financial statements of the Company.

8.2 Standards issued but not yet effective

The new and amended standards and interpretations that are issued, but not yet effective, up to the date of issuance
of the financial statements are disclosed below. The Company will adopt this new and amended standard, when it
becomes effective.

Ind AS 1 - Classification of Liabilities as Current or Non-current and Non-current Liabilities with Covenants

The amendment requires that if a covenant breach is rectified after the reporting date, the same will be treated as a
non-adjusting event and this amendment will be applicable from annual reporting periods beginning on or after the 1
April 2026.

The amendments are not expected to have a material impact on these financial statements of the Company.

22.6 The Company has neither alloted any shares as fully paid up pursuant to contract without payment being received in cash
and by way of bonus shares nor bought back any shares during the period of five years preceding the date of this balance
sheet.

22.7 In accordance with SEBI regulations, during the year ended 31 March 2024, with the approval of members by the Special
resolution in the Extra Ordinary General meeting held on 18 November 2023, the Day to Day affairs committee of the Board
of Directors of the Company, in its meeting held on 21 March 2024, approved the allotment of 20,00,000 convertible share
warrants to promoter group company on preferntial basis at issue price of ' 120 per warrant. Each warrant is convertible
into 1 fully paid equity share of ' 10 each. 25% of warrant issue price has been received upfront against each warrant.
During the year the warrant holders exercised their option for conversion after payment of the balance subscription amount
of ' 90 per warrant and accordingly the company with the approval of Day to Day affairs committee of the Board of
Directors in its meeting held on 18 September 2025 alloted 20,00,000 equity shares if face walue of ' 10 each. Consequent
to such allotment equity share capital increased by ' 200 Lakhs and securities premium account increased by ' 2,200
Lakhs. The equity shares alloted pursuant to the conversion rank pari passu with the existing equity shares of the company
in all respects, including voting rights and dividend entitlement.

22.8 The Company is not a subsidiary company.

28.1 Working Capital loans are secured by first pari-passu charge on current assets including few brands of the Company,
second charge on both present and future fixed assets of the company and Pledge of unencumbered shareholding in
the company held by Expert Chemicals (I) Private Limited & Kingsbury Investment Inc. and Pledge of 12,71,250 shares
of Bravo Healthcare ltd and pledge of 5 shares of Wanbury Global FZE on pari passu basis. Further there is Corporate
Guarantee of Experts Chemicals , Bravo Healthcare, Wanbury Global FZE and Kingsbury investments and Personal
Guarantee of Mr. K Chandran, Director of the Company.

28.2 Factoring facilities are secured by subservient (residual) charge on all present and future receivables, book debts,
outstandings, monies receivables, claims and bills of the company, which are now due and or which may be due at anytime
of its approved debtors and subservient charge on all present and future fixed asset and current assets of the Company.

The management considers the Service Tax, Custom Duty, Sales Tax, GST, Income Tax etc. demand received from the
authorities and demand received from NPPA are not tenable against the Company, and therefore no provision for these
contingencies has been made. Further, in respect of aforesaid matters, the Company does not expect to have any material
adverse effect on the Company's financial conditions, results of operations or cash flows. Future cash flows in respect of
liability under clause (a) to (g) are dependent on decisions by relevant authorities of respective disputes.

45. Details of Exceptional items are as under:

Effective 21 November, 2025, The Government of India has consolidated multiple existing labour legislations into a unified
framework comprising four Labour Codes collectively referred to as the 'New Labour Codes'. The Company has assessed
the financial implications of these changes which has resulted in increase in gratuity liability arising out of past service cost
and increase in leave liability by ' 360.39 Lakhs primarily arising due to change in the definition of “wages” for employees
and contract labours. Considering the materiality and non-recuring nature of this impact, the Company has presented such
incremental impact under “Exceptional Item”- in the financial results for the year ended 31 March 2026.

The investments in these subsidiaries had been fully impaired in earlier years. Consequently, during the year, the Company
wrote off the carrying value of the investments along with the corresponding impairment provision. As the investments had
already been fully provided for, the write-off has no impact on the Statement of Profit and Loss.

47. Segment ReportingA. Basis for Segmentation :

The operations of the Company are limited to one segment viz. Pharmaceutical and related products. The products
being sold under this segment are of similar nature and comprises of pharmaceutical products only.

The Chief Operating Decision Maker reviews the internal management reports prepared based on an aggregation of
financial information on a periodic basis.

As required by Ind AS 19 “Employees Benefits” the disclosures are as under:

Defined Contribution Plans

The Company offers its employees defined contribution plans in the form of Provident Fund (PF) and Employees' Pension
Scheme (EPS) with the Government, and certain State plans such as Employees' State Insurance (ESI), PF and EPS cover
substantially all regular employees and the ESI covers certain employees. Contributions are made to the Government's
funds. While both the employees and the Company pay predetermined contributions into the provident fund and the ESI
Scheme, contributions into the pension fund is made only by the Company. The contributions are normally based on a
certain proportion of the employee's salary.

Defined Benefit Plans

Gratuity: Under the gratuity plan, the eligible employees are entitled to post -retirement benefit at the rate of 15 days salary
for each year of service until the retirement or resignation with a payment ceiling of ' 20 lakhs. Company's liability towards
gratuity is determined using the Projected Unit Credit Method as per the actuarial valuation carried out at the Balance
Sheet date.

The sensitivity analysis presented above may not be representative of the actual change in the defined benefit obligation
as it is unlikely that the change in assumptions would occur in isolation of one another as some of the assumptions may be
correlated.

Although the analysis does not take into account full distribution of cash flows expected under the plan, it does provide
an approximation of sensitivity of assumptions. The estimate of future increase in compensation levels, considered in the
actuarial valuation, have been taken on account of inflation, seniority, promotion and other relevant factors such as supply
and demand in the employment market.

The expected contribution for Defined Benefit Plan for the next financial year will be in line with current financial year.

The Average outstanding terms of obligations (years) as at valuation date is 5.46 years (Pr. Yr. 10.71 years).

The Company provides for death benefit, a defined benefit plan, (the death benefit plan) to certain categories of employ¬
ees. The death benefit plan provides a lump sum payment to vested employees on death, being compensation received
from the insurance company and restricted to limits set forth in the said plan. The Company makes annual contribution to
Group Gratuity Cash Accumulation Plan of LIC, a funded plan for qualifying employees.

Leave Encashment:

The Company's employees are entitled for compensated absences which are allowed to be accumulated and encashed as
per the Company's rule. The liability of compensated absences, which is non-funded, has been provided based on report
of independent actuary using the “Projected Unit Credit Method”.

Accordingly aggregate of ' 805.19 Lakhs (Pr. Yr. ' 607.30 Lakhs) being liability as at the year end for compensated ab¬
sences as per actuarial valuation has been provided in the accounts.

A. Actuarial Risk:

It is the risk that benefits will cost more than expected. This can arise due to one of the following reasons:

Adverse Salary Growth Experience: Salary hikes that are higher than the assumed salary escalation will result into
an increase in Obligation at a rate that is higher than expected.

Variability in mortality rates:

If actual mortality rates are higher than assumed mortality rate assumption than the Gratuity Benefits will be paid
earlier than expected. Since there is no condition of vesting on the death benefit, the acceleration of cashflow will lead
to an actuarial loss or gain depending on the relative values of the assumed salary growth and discount rate.

If actual mortality rates are higher than assumed mortality rate assumption than the leave benefit will be paid earlier
than expected. The acceleration of cashflow will lead to an actuarial loss or gain depending on the relative values of
the assumed salary growth and discount rate.

Variability in withdrawal rates:

If actual withdrawal rates are higher than assumed withdrawal rate assumption than the Gratuity Benefits will be paid
earlier than expected. The impact of this will depend on whether the benefits are vested as at the resignation date.

If actual withdrawal rates are higher than assumed withdrawal rate assumption than the leave benefit will be paid
earlier than expected. The impact of this will depend on the relative values of the assumed salary growth and discount
rate.

Variability in availment rates:

If actual availment rates are higher than assumed availment rate assumption then leave balances will be utilised
earlier than expected. This will result in reduction in leave balances and Obligation.

B. Investment Risk:

For funded plans that rely on insurers for managing the assets, the value of assets certified by the insurer may not be
the fair value of instruments backing the liability. In such cases, the present value of the assets is independent of the
future discount rate. This can result in wide fluctuations in the net liability or the funded status if there are significant
changes in the discount rate during the inter-valuation period.

C. Liquidity Risk:

Employees with high salaries and long durations or those higher in hierarchy, accumulate significant level of benefits.
If some of such employees resign/retire from the Company there can be strain on the cashflows.

D. Market Risk:

Market risk is a collective term for risks that are related to the changes and fluctuations of the financial markets. One
actuarial assumption that has a material effect is the discount rate. The discount rate reflects the time value of money.
An increase in discount rate leads to decrease in Defined Benefit Obligation of the plan benefits & vice versa. This
assumption depends on the yields on the corporate/government bonds and hence the valuation of liability is exposed
to fluctuations in the yields as at the valuation date.

E. Legislative Risk:

Legislative risk is the risk of increase in the plan liabilities or reduction in the plan assets due to change in the legisla-
tion/regulation. The government may amend the Payment of Gratuity Act thus requiring the companies to pay higher
benefits to the employees. This will directly affect the present value of the Defined Benefit Obligation and the same
will have to be recognised immediately in the year when any such amendment is effective.

53. Employees Stock Options Plan (‘ESOP')

The Company has established an Employee Stock Options Plan 2016 ('WANBURY ESOP - 2016') which was approved
by the shareholders vide their resolution dated 29 September 2016. The options issued under the above scheme vest in
phased manner. Each option entitles an employee to subscribe to one equity share of the Company at an exercise price of
' 10 per share for all options issued prior to 05.02.2026 and ' 130 per share for options issued on 05.02.2026.

54. Disclosure for leases under Ind AS 116- “Leases”:

The Company has taken various premises on lease. Rental contracts are made from 12 months to 60 months and are re¬
newable by mutual consent on mutually agreeable terms. Some of these lease agreements have price escalation clauses.
There are no restriction imposed by lease agreements and there are no sub leases. There are no contingent rents.

The Company has adopted Ind AS 116 effective from 1 April 2019, using the modified retrospective method.

Right-of-use assets is depreciated on a straight-line basis over the shorter of the lease term and useful life of the asset.

Terms and Conditions of transactions with related parties

Company has completed an independent evaluation for all transactions, for the year ended 31.03.2026 and for the year
ended 31.03.2025 to determine whether the transactions with associate enterprises are undertaken at arm's length price
based on the internal pricing review and validation, Company believes that all transaction with associated enterprises are
in the ordinary course of the business and on arm's length basis.

For the year ended 31.03.2026 and for the year ended 31.03.2025 the Company has not recorded any impairment of
receivables relating to amounts owed by related parties. This assessment is undertaken each financial year through exam¬
ining the financial position of the related party and the market in which the related party operates.

Outstanding balances at the year-end are unsecured and settlement occurs in cash.

Disclosure of transactions between Company and Related Parties during the year which are more than 1% of Revenue
There were no transactions between Company and Related Parties during the year which are more than 1% of revenue.
57. Capital Management:

The primary objective of the Company's capital management is to maximise shareholder value. The capital structure of the
Company is based on the management's judgement of its strategic and day-to-day needs with a focus on total equity so
as to maintain investor, creditors and market confidence.

Management monitors the return of capital, as well as the level of dividends paid to equity shareholders. The board of di¬
rectors seeks to maintain a balance between the higher returns that might be possible with higher levels of borrowing and
advantages and security afforded by a sound capital position.

For the purpose of the Company's capital management, the Company monitors Net Debts and Equity.

Equity includes all components of equity i.e. paid up equity capital, share premium and all other equity reserves attributable
to the equity holders of the Company.

Net Debt includes total liabilities comprising interest bearing loans and borrowings less cash and cash equivalents.

Details of the Equity and Net Debts are as under:

B. Fair Value Measurements
Fair Value Hierarchy

This section explains the judgements and estimates made in determining the fair values of the financial instruments that
are (a) recognised and measured at fair value and (b) measured at amortised cost and for which fair values are disclosed
in the financial statements. To provide an indication about the reliability of the inputs used in determining fair value, the
Company has classified its financial instruments into the three levels prescribed under the Indian Accounting Standard. An
explanation of each level is as follows:

Level 1: Level 1 hierarchy includes financial instruments measured using quoted prices in active markets or identical as¬
sets and liabilities.

Level 2: The fair value of financial instruments that are not traded in an active market (like forward contracts) is determined
using valuation techniques which maximise the use of observable market data and rely as little as possible on entity spe¬
cific estimates.If all significant inputs required to fair value as instrument are observable, the instrument is
included in level 2

Level 3: If one or more of the significant inputs is not based on observable market data, the instrument is included in level3.
This is the case for unlisted equity securities etc. included in level 3.

Valuation techniques used to determine fair value

The fair value of the quoted investment is determined using traded quoted bid prices in an active market. The fair value of
unquoted investments is determined using inputs other than quoted prices included in level 1 that are observable for assets
and liabilities.

C. Financial Risk Management

The Company has exposure to following risks arising from financial instruments:

> Credit Risk

• Trade Receivables

• Other Financial Instruments

> Liquidity Risk

> Market Risk

• Currency Risk

• Interest Rate Risk

• Price Risk

i. Risk Management Framework

The Company's board of directors has overall responsibility for the establishment and oversight of the Company's
risk management framework. Management is responsible for developing and monitoring the Company's risk man¬
agement policies, under the guidance of Audit Committee.

The Company's risk management policies are established to identify and analyse the risks faced by the Company, to
set appropriate risk limits and controls and to monitor risks and adherence to limits. Risk management policies and
systems are reviewed regularly to reflect changes in market conditions and the Company's activities. The Company,
through its training and management standards and procedures, aims to maintain a disciplined and constructive
control environment in which all employees understand their roles and obligation.

The Company's Audit committee oversees how management monitors compliance with the Company's risk manage¬
ment policies and procedures, and reviews the adequacy of the risk management framework in relation to the risks
faced by the Company. The Audit committee is assisted in its oversight role by internal audit. Internal audit under¬
takes both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported
to the Audit committee.

ii. Credit Risk

Credit risk is the risk that a counter party will not meet its obligations under a financial instrument or customer con¬
tract, leading to a financial loss. The Company is exposed to credit risk from its operating activities (primarily trade
receivables) and from its financing activities, including deposits with banks, foreign exchange transactions and other
financial instruments.

(a) Trade Receivables

Customer credit risk is managed by the Company subject to Company's established policy, procedures and control
relating to customer credit risk management. Trade receivables are mainly from manufacturers, non-interest bearing
and are generally on 7 days to 90 days credit term. Credit limits are established for all customers based on internal
rating criteria and any deviation in credit limit require approval of Directors. Outstanding customer receivables are
regularly monitored. The Company has no concentration of credit risk as the customer base is widely distributed both
economically and geographically.

An impairment analysis is performed at each reporting date on an individual basis for major clients. In addition, a
large number of minor receivables are grouped into homogenous groups and assessed for impairment collectively.
The calculation is based on historical data. The maximum exposure to credit risk at the reporting date is the carrying
value of each class of financial assets. The Company does not hold collateral as security. The Company evaluates
the concentration of risk with respect to trade receivables as low, as its customers are located in several jurisdictions
and operate in largely independent markets. Trade receivables do not contain any significant financing component
and hence, the Company recognises life time expected credit loss based on simplified approach.

(b) Other Financial Instruments

The credit risk on liquid funds and derivative financial instruments is limited because the counterparties are banks
or financial institutions with high credit rating assigned by credit rating agencies. For other financial assets, the
Company assesses and manages the credit risk internally. The Company considers the probability of default upon
initial recognition and assess whether there has been a significant increase in credit risk subsequently based in the
historical losses and forward looking supportable information. Based on general approach, if there is a significant
increase in credit risk of a financial asset since its initial recognition the Company recognises life time expected credit
loss otherwise 12 months expected credit loss is recognised.

iii. Liquidity Risk

Liquidity risk is the risk that the Company may not be able to meet its present and future cash and collateral obligations
without incurrin unacceptable losses. The Company's objective is to maintain optimum level of liquidity at all times,
to meet its cash and collateral requirements. The Company closely monitors its liquidity position and deploys a
robust cash management system. It maintains adequate sources of financing including bilateral loans, debt etc. at an
optimised cost. Working capital requirements are adequately addressed by internally generated and borrowed funds.

The following tables detail the Company's remaining contractual maturity for its financial liabilities with agreed
repayment periods. The tables have been drawn up based on the undiscounted cash flows of financial liabilities
based on the earliest date on which the Company can be required to pay. The tables include both interest and
principal cash flows. To the extent that interest flows are at floating rate, the undiscounted amount is derived from
interest rate curves at the end of the reporting period.

iv. Market risk

Market risk is the risk that changes in market prices - such as foreign exchange rates, interest rates and equity
prices - will affect the Company's income or the value of its holdings of financial instruments. The objective of market
risk management is to manage and control market risk exposures within acceptable parameters, while optimising
the return. Financial instruments affected by market risk include loans and borrowings, deposits, investments, and
derivative financial instruments.

The Company's activities expose it to a variety of financial risks, including the effects of changes in foreign currency
exchange rates and interest rates. The Company uses derivative financial instruments such as foreign exchange
contracts to manage its exposures to foreign exchange fluctuations. All such transactions are carried out within the
guidelines set by the risk management committee.

The analysis excludes the impact of movements in market variables on the carrying value of post-employment benefit
obligations, provisions and on the non financial assets and liabilities.

(a) Currency Risk

The Company is exposed to currency risk to the extent that there is a mismatch between the currencies in which
sales, purchases and borrowings are denominated and the functional currency of the Company.

The currencies in which these transactions are primarily denominated are US dollars (US $), Pound (GBP) and Euro.

As the share of exports to total sales made by the Company is considerable, same is partly hedge through natural
hedging via raw material imports. Further management exercise close monitoring of currency fluctuations.

During the year, the Company has entered into forward exchange contract, being derivative instrument to mitigate
foreign currency risk, to establish the amount of currency in India Rupees required or available at the settlement date
of certain payables and receivables.

(b) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of
changes in market interest rates.

Majority of borrowings of the Company are at fixed interest rate and are carried at amortised cost. They are therefore
not subject to interest rate risks, since neither the carrying amount nor the future cash flows will fluctuate because off
a change in market interest rates.

(c) Price risk

The Company is exposed to equity price risks arising from equity investments. However, there is no material impact
of the sensitivity.

59. Revenue (Ind AS 115)

The operations of the Company are limited to only one segment viz. pharmaceuticals and related products. Revenue from
contract with customers is from sale of manufactured/traded goods. Sale of goods are made at a point in time and revenue
is recognised upon satisfaction of the performance obligations which is typically upon dispatch / delivery. The Company
has a credit evaluation policy based on which the credit limits for the trade receivables are established. The credit period
provided by the Company is not significant, hence there is no significant financing component.

65. Compliance with approved Scheme(s) of Arrangements:

The Company has not entered into any Scheme of Arrangements in terms of sections 230 to 237 of the Companies Act,
2013 which has accounting impact on current or previous financial year.

66. Utilisation of borrowed funds and share premium:

A. During the year, the Company has not advanced or loaned or invested funds to any other person(s) or entity(ies),
including foreign entities (Intermediaries) with the understanding that the Intermediary shall:

a. directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the company (Ultimate Beneficiaries) or

b. provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

B. During the year, the Company has not received any fund from any person(s) or entity(ies), including foreign entities
(Funding Party) with the understanding (whether recorded in writing or otherwise) that the Company shall:

a. directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the Funding Party (Ultimate Beneficiaries) or

b. provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

68. Previous year's figures have been re-grouped / re-classified wherever necessary, to confirm to current year's classification